PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsarterial occlusive diseases
MeSH D001157 - arterial occlusive diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014652:Vascular diseases
$
Success rate
D001157: 
Arterial occlusive diseases
$
Success rate
D000071079:Pulmonary artery stenosis
0 Companies
0 Drugs
Success rate
D000074742:Median arcuate ligament syndrome
0 Companies
0 Drugs
Success rate
D000083082:Popliteal artery entrapment syndrome
0 Companies
0 Drugs
Success rate
D001161:Arteriosclerosis
$
Success rate
D005352:Fibromuscular dysplasia
0 Companies
0 Drugs
Success rate
D007925:Leriche syndrome
0 Companies
0 Drugs
Success rate
D008641:Mesenteric vascular occlusion
0 Companies
0 Drugs
Success rate
D009072:Moyamoya disease
0 Companies
0 Drugs
Success rate
D012078:Renal artery obstruction
0 Companies
0 Drugs
Success rate
D013919:Thromboangiitis obliterans
$
Success rate
D015356:Retinal artery occlusion
0 Companies
0 Drugs
Success rate
D016893:Carotid stenosis
0 Companies
0 Drugs
Success rate
D054853:Malignant atrophic papulosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
GenentechAlteplase Cathflo Activase  1987-11-13   
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
56%
5/9
Phase 3
19%
5/26
Approved: 2Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Genentech
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use